Every single PDUFA reauthorization generates a “ought to move” legislative motor vehicle on which market can target its Power and lobbying efforts, which Congress must then take into consideration and vote on in just a confined time-frame, constraining its capability to substantially revise the commitments ensuing from FDA-field negotiation.???